Resmed has named Salli Schwartz as chief investor relations officer, where she will lead the company’s global investor relations function and report to Mick Farrell, chairman of the board ...

Former Illumina, MSCI, and Moody’s executive brings extensive experience leading engagement with the global investment communitySAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: ...

ResMed has appointed Salli Schwartz as the new Chief Investor Relations Officer, effective April 21, 2025. Schwartz brings over two decades of experience from roles in finance at health tech and ...

Resmed (RMD) announced the appointment of Salli Schwartz as Chief Investor Relations Officer, effective April 21. In this role, Schwartz will ...

today announced the appointment of Salli Schwartz as Chief Investor Relations Officer, effective April 21, 2025. In this role, Schwartz will lead Resmed's global investor relations function and ...